Verisante Named Edison Awards Finalist
Aura to Be Recognized at Edison Awards Gala on April 25, 2013 in Chicago
(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 02/13/13 -- (TSX VENTURE: VRS)(OTCQX: VRSEF)(FRANKFURT: V3T) (the "Company" or "Verisante"), a leader in cancer detection technology, announced today that Verisante Aura™, a revolutionary skin cancer detection device, has been named a 2013 finalist by the internationally renowned Edison Awards™. The distinguished awards symbolize the persistence and excellence personified by Thomas Alva Edison, inspiring creative minds to remain in the forefront of innovation, creativity and ingenuity in the global economy.
"More than we have seen at any other time previously, this year's slate of finalists demonstrate the enormous value of teamwork, experimentation, consumer focus, market awareness and game-changing success," said Frank Bonafilia, Edison Awards' executive director. "It's exciting to see companies like Verisante continuing Thomas Edison's legacy of challenging conventional thinking."
"It is an honour to be selected as an Edison Awards finalist," said Thomas Braun, President & CEO of Verisante. "Aura™ is a game-changing innovation that will significantly improve patient outcomes and care. It has taken some of the field's brightest minds and years of research and commitment to bring this technology to commercialization."
The ballot of nominees for the Edison Awards is judged by more than 3,000 senior business executives and academics from across the nation whose votes acknowledge the finalists' success in meeting the award criteria of Concept, Value, Delivery and Impact. The panel includes members of the Marketing Executives Networking Group (MENG), the American Association Advertising Agencies (4As), the Chief Marketing Officer Council (CMO), the Design Management Institute (DMI), the American Productivity & Quality Center (APQC), the American Society of Mechanical Engineers (ASME) and the Association of Technology Management & Applied Engineering (ATMAE). Also on the panel are hundreds of past Edison Award winners, marketing professionals, scientists, designers, engineers and academics.
Award winners will be announced April 25, 2013 at the Edison Awards Annual Gala, held in the Grand Ballroom at historic Navy Pier in Chicago, IL.
About the Edison Awards
The Edison Awards is a program conducted by Edison Universe, a 501(c)(3) charitable organization dedicated to fostering future innovators. The 2013 Edison Awards are sponsored by Nielsen, Discovery Communications, Science Channel, and USA Today. For more information about the Edison Awards, Edison Universe and a list of past winners, visit .
About Verisante Technology, Inc.
committed to . The and the utilize a proprietary cancer detection platform while the operating software and probe technology are unique to each device. The cancer detection platform was developed by the BC Cancer Agency and tested and refined at the Skin Care Centre at Vancouver General Hospital. This exclusive platform technology allows Verisante to develop and offer a range of compact, for many of the most common cancers. Aura™ has been approved for sale in Canada, Europe and Australia. The Core™ has not yet been approved for sale.
Verisante Aura™ was awarded Popular Science Magazine's "" for 2011, and awarded a for Innovation in Photonics. Verisante Core™ was named one of the of 2011 by the Canadian Cancer Society.
Website:
Youtube:
Twitter:
Facebook:
Forward Looking Statements
This release contains forward-looking statements, including, but not limited to, statements regarding the future commercialization of medical devices, the market demand for these products and the proprietary protections the Company will obtain with regard to the technology, all of which statements are subject to market risks, and the possibility that the Company will not be able to obtain patent protection or obtain sufficient customer demand. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties.
The TSX Venture Exchange has neither approved nor disapproved of the contents of this press release. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.
Contacts:
Verisante Technology, Inc.
Thomas Braun
President & CEO
(604) 605-0507
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 13.02.2013 - 08:30 Uhr
Sprache: Deutsch
News-ID 1196634
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
VANCOUVER, BRITISH COLUMBIA
Phone:
Kategorie:
Hospitals, Facilities and Providers
Anmerkungen:
Diese Pressemitteilung wurde bisher 159 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Verisante Named Edison Awards Finalist
"
steht unter der journalistisch-redaktionellen Verantwortung von
Verisante Technology, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
